Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call
LONDON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it will host a...
Staff
Verrica Pharmaceuticals Reports Second Quarter 2023 Financial Results
– In July, FDA approved YCANTH™ for the treatment of molluscum, a highly contagious viral skin infection affecting approximately 6...
Anavex Life Sciences Reports Fiscal 2023 Third Quarter Financial Results
On track to release top-line data of potentially pivotal ANAVEX®2-73-RS-003 Phase 2/3 EXCELLENCE pediatric clinical trial in the second half...
Harvard Bioscience Announces Second Quarter 2023 Financial Results
Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove...
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
Actions bring sharpened focus on MCM and NARCAN® Nasal Spray products Expected to improve operational efficiencies and deliver annual cost...
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023
Robust growth and efficient expense execution continuesBOSTON and ROLLE, Switzerland, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq:...
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
Announced Positive Topline Results from CT1812 Phase 2 SEQUEL Study in Mild-to-Moderate Alzheimer’s Disease Commenced Recruitment for 540-patient Phase 2...
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
– Enrollment continues globally in multiple clinical studies of vepdegestrant (ARV-471), including VERITAC-2 2L Phase 3 trial and study lead-in...
Medicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committee
Development Advisory Committee strengthened with the expertise and leadership of Dr. YavariTORONTO and HOUSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) --...
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market
Oakville, Ontario--(Newsfile Corp. - August 8, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
DEA Delays MMJ Company Marijuana Research, Clinical Trials and Pharma Development as Patients Suffer
DEA is Mismanaging the Marijuana Registration Process as UMISS is Still the Only ProviderThe DEA is Perpetuating a Ruse on...
Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe
PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / August 8, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"),...
Inogen Announces Second Quarter 2023 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Black Book Announces 2023 Top Client-Rated Supply Chain Solutions Delivering Digital Transformation and Operational Responsibility
Over 5,000 materials management and purchasing professionals were represented in the sweeping series of supply chain IT user polls, as...
Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023
STONY BROOK, NY / ACCESSWIRE / August 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
America’s Mental Health Crisis: Can Science Help End the Medication Guessing Game?
Fast-Tracking Relief: How RxGenomix's ExactMeds is Pioneering DNA-Guided Mental Health TreatmentFRANKLIN, TN / ACCESSWIRE / August 7, 2023 / Mental...
Top Client-Rated Healthcare Supply Chain Solutions Exhibiting at AHRMM23 Annual Meeting, Black Book Research User Survey
Black Book Research recognizes the top-performing tech and managed services firms based on the industry's largest client survey of five...
CBD of Denver Wants to Provide an Update on Progress with the Company and Additional Corporate Updates
Denver, Colorado--(Newsfile Corp. - August 7, 2023) - CBD of Denver (OTC Pink: CBDD) would like to update its shareholders...
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
Model N Earns Recognition for Company Culture, Named by Fortune as a Best Place to Work for Millennial Employees
Revenue optimization and compliance leader included in Fortune’s 2023 Best Workplaces for Millennials listSAN MATEO, Calif.--(BUSINESS WIRE)--Fortune Media and Great...